Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 92 Breast Neoplasms 69 Prostatic Neoplasms 33 Triple Negative Breast Neoplasms 32 Neoplasms 26 Fallopian Tube Neoplasms 25 Neoplasm Metastasis 21 Endometrial Neoplasms 19 Pancreatic Neoplasms 18 Small Cell Lung Carcinoma 13 Carcinoma, Ovarian Epithelial 12 Carcinoma, Non-Small-Cell Lung 10 Stomach Neoplasms 9 Sarcoma 9 Recurrence 9 Lung Neoplasms 9 Fanconi Anemia, Complementation Group D1 9 Squamous Cell Carcinoma of Head and Neck 8 Glioma 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Glioblastoma 7 Colorectal Neoplasms 6 Metastatic Castration-resistant Prostate Cancer 5 Lymphoma, Non-Hodgkin 5 Cholangiocarcinoma 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Solid Tumors 4 Osteosarcoma 4

Interventions

Radiotherapy 38 Radiotherapy, Intensity-Modulated 12 Cisplatin 12 Amifostine 11 Paclitaxel 7 Carboplatin 7 Radiosurgery 6 Etoposide 5 Brachytherapy 5 Surgical Procedures, Operative 4 Low-Level Light Therapy 4 Donepezil 4 Chemotherapy, Adjuvant 4 Bevacizumab 4 sargramostim 3 Surveys and Questionnaires 3 Radiation 3 Proton Therapy 3 Neuropsychological Tests 3 Mental Status and Dementia Tests 3 Magnetic Resonance Spectroscopy 3 Heavy Ion Radiotherapy 3 Filgrastim 3 Diet Therapy 3 Chemoradiotherapy 3 Blood Specimen Collection 3 Radiotherapy, Conformal 2 Radiation Dose Hypofractionation 2 Patient Reported Outcome Measures 2 Lithium 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Radiation Injuries × olaparib × Clear all

NCT03109080 2025-11-24

RadioPARP

Institut Curie

Phase 1 Completed

Radiation Injuries, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡